AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
156.89
+0.44 (0.28%)
At close: Aug 17, 2026, 4:00 PM EDT
156.95
+0.06 (0.04%)
After-hours: Aug 17, 2026, 7:52 PM EDT

AstraZeneca Revenue

AstraZeneca had revenue of $15.38B in the quarter ending June 30, 2026, with 6.41% growth. This brings the company's revenue in the last twelve months to $61.37B, up 8.61% year-over-year. In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth.

Revenue (ttm)
$61.37B
Revenue Growth
+8.61%
P/S Ratio
3.96
Revenue / Employee
$645,279
Employees
95,100
Market Cap
243.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 201822.09B-375.00M-1.67%
Dec 31, 201722.47B-537.00M-2.33%
Dec 31, 201623.00B-1.71B-6.90%
Dec 31, 201524.71B-1.84B-6.93%
Dec 31, 201426.55B741.00M2.87%
Dec 31, 201325.81B-2.17B-7.75%
Dec 31, 201227.97B-5.62B-16.72%
Dec 31, 201133.59B322.00M0.97%
Dec 31, 201033.27B465.00M1.42%
Dec 31, 200932.80B1.20B3.81%
Dec 31, 200831.60B2.04B6.91%
Dec 31, 200729.56B3.08B11.65%
Dec 31, 200626.48B2.53B10.54%
Dec 31, 200523.95B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
Merck & Co.66.57B
AbbVie64.39B
Pfizer63.70B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Bristol-Myers Squibb Company49.19B
Revenue Rankings